Table of Content

1 Anti-PD-1 Antibody Market Overview
1.1 Anti-PD-1 Antibody Product Overview
1.2 Anti-PD-1 Antibody Market Segment by Type
1.2.1 Monoclonal
1.2.2 Polyclonal
1.3 Global Anti-PD-1 Antibody Market Size by Type
1.3.1 Global Anti-PD-1 Antibody Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-PD-1 Antibody Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-PD-1 Antibody Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-PD-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-PD-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-PD-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-PD-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-PD-1 Antibody Sales Breakdown by Type (2018-2024)
2 Global Anti-PD-1 Antibody Market Competition by Company
2.1 Global Top Players by Anti-PD-1 Antibody Sales (2018-2024)
2.2 Global Top Players by Anti-PD-1 Antibody Revenue (2018-2024)
2.3 Global Top Players by Anti-PD-1 Antibody Price (2018-2024)
2.4 Global Top Manufacturers Anti-PD-1 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-PD-1 Antibody Market Competitive Situation and Trends
2.5.1 Anti-PD-1 Antibody Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-PD-1 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-PD-1 Antibody Market
2.8 Key Manufacturers Anti-PD-1 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-PD-1 Antibody Status and Outlook by Region
3.1 Global Anti-PD-1 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-PD-1 Antibody Historic Market Size by Region
3.2.1 Global Anti-PD-1 Antibody Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-PD-1 Antibody Sales in Value by Region (2018-2024)
3.2.3 Global Anti-PD-1 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-PD-1 Antibody Forecasted Market Size by Region
3.3.1 Global Anti-PD-1 Antibody Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-PD-1 Antibody Sales in Value by Region (2024-2029)
3.3.3 Global Anti-PD-1 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-PD-1 Antibody by Application
4.1 Anti-PD-1 Antibody Market Segment by Application
4.1.1 IHC-P
4.1.2 ICC/IF
4.1.3 WB
4.1.4 Flow Cytometry
4.1.5 ELISA
4.2 Global Anti-PD-1 Antibody Market Size by Application
4.2.1 Global Anti-PD-1 Antibody Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-PD-1 Antibody Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-PD-1 Antibody Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-PD-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-PD-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-PD-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-PD-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-PD-1 Antibody Sales Breakdown by Application (2018-2024)
5 North America Anti-PD-1 Antibody by Country
5.1 North America Anti-PD-1 Antibody Historic Market Size by Country
5.1.1 North America Anti-PD-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-PD-1 Antibody Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-PD-1 Antibody Sales in Value by Country (2018-2024)
5.2 North America Anti-PD-1 Antibody Forecasted Market Size by Country
5.2.1 North America Anti-PD-1 Antibody Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-PD-1 Antibody Sales in Value by Country (2024-2029)
6 Europe Anti-PD-1 Antibody by Country
6.1 Europe Anti-PD-1 Antibody Historic Market Size by Country
6.1.1 Europe Anti-PD-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-PD-1 Antibody Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-PD-1 Antibody Sales in Value by Country (2018-2024)
6.2 Europe Anti-PD-1 Antibody Forecasted Market Size by Country
6.2.1 Europe Anti-PD-1 Antibody Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-PD-1 Antibody Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-PD-1 Antibody by Region
7.1 Asia-Pacific Anti-PD-1 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Anti-PD-1 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-PD-1 Antibody Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-PD-1 Antibody Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-PD-1 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-PD-1 Antibody Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-PD-1 Antibody Sales in Value by Region (2024-2029)
8 Latin America Anti-PD-1 Antibody by Country
8.1 Latin America Anti-PD-1 Antibody Historic Market Size by Country
8.1.1 Latin America Anti-PD-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-PD-1 Antibody Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-PD-1 Antibody Sales in Value by Country (2018-2024)
8.2 Latin America Anti-PD-1 Antibody Forecasted Market Size by Country
8.2.1 Latin America Anti-PD-1 Antibody Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-PD-1 Antibody Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-PD-1 Antibody by Country
9.1 Middle East and Africa Anti-PD-1 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Anti-PD-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-PD-1 Antibody Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-PD-1 Antibody Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-PD-1 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-PD-1 Antibody Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-PD-1 Antibody Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bio X Cell
10.1.1 Bio X Cell Company Information
10.1.2 Bio X Cell Introduction and Business Overview
10.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bio X Cell Anti-PD-1 Antibody Products Offered
10.1.5 Bio X Cell Recent Development
10.2 Thermo Fisher
10.2.1 Thermo Fisher Company Information
10.2.2 Thermo Fisher Introduction and Business Overview
10.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Thermo Fisher Anti-PD-1 Antibody Products Offered
10.2.5 Thermo Fisher Recent Development
10.3 InvivoGen
10.3.1 InvivoGen Company Information
10.3.2 InvivoGen Introduction and Business Overview
10.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.3.4 InvivoGen Anti-PD-1 Antibody Products Offered
10.3.5 InvivoGen Recent Development
10.4 BioVision Inc
10.4.1 BioVision Inc Company Information
10.4.2 BioVision Inc Introduction and Business Overview
10.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.4.4 BioVision Inc Anti-PD-1 Antibody Products Offered
10.4.5 BioVision Inc Recent Development
10.5 Abcam
10.5.1 Abcam Company Information
10.5.2 Abcam Introduction and Business Overview
10.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Abcam Anti-PD-1 Antibody Products Offered
10.5.5 Abcam Recent Development
10.6 Bristol-Myers Squibb (BMS)
10.6.1 Bristol-Myers Squibb (BMS) Company Information
10.6.2 Bristol-Myers Squibb (BMS) Introduction and Business Overview
10.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Products Offered
10.6.5 Bristol-Myers Squibb (BMS) Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck Anti-PD-1 Antibody Products Offered
10.7.5 Merck Recent Development
10.8 Ono Pharmaceutical Co., Ltd
10.8.1 Ono Pharmaceutical Co., Ltd Company Information
10.8.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
10.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
10.8.5 Ono Pharmaceutical Co., Ltd Recent Development
10.9 Lilly
10.9.1 Lilly Company Information
10.9.2 Lilly Introduction and Business Overview
10.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Lilly Anti-PD-1 Antibody Products Offered
10.9.5 Lilly Recent Development
10.10 Chugai Pharmaceutical Co., Ltd
10.10.1 Chugai Pharmaceutical Co., Ltd Company Information
10.10.2 Chugai Pharmaceutical Co., Ltd Introduction and Business Overview
10.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Products Offered
10.10.5 Chugai Pharmaceutical Co., Ltd Recent Development
10.11 BeiGene
10.11.1 BeiGene Company Information
10.11.2 BeiGene Introduction and Business Overview
10.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.11.4 BeiGene Anti-PD-1 Antibody Products Offered
10.11.5 BeiGene Recent Development
10.12 Abbvie
10.12.1 Abbvie Company Information
10.12.2 Abbvie Introduction and Business Overview
10.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Abbvie Anti-PD-1 Antibody Products Offered
10.12.5 Abbvie Recent Development
10.13 TG Therapeutics, Inc
10.13.1 TG Therapeutics, Inc Company Information
10.13.2 TG Therapeutics, Inc Introduction and Business Overview
10.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Products Offered
10.13.5 TG Therapeutics, Inc Recent Development
10.14 Novartis
10.14.1 Novartis Company Information
10.14.2 Novartis Introduction and Business Overview
10.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Novartis Anti-PD-1 Antibody Products Offered
10.14.5 Novartis Recent Development
10.15 Arcus Biosciences
10.15.1 Arcus Biosciences Company Information
10.15.2 Arcus Biosciences Introduction and Business Overview
10.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Arcus Biosciences Anti-PD-1 Antibody Products Offered
10.15.5 Arcus Biosciences Recent Development
10.16 Sino Biological Inc
10.16.1 Sino Biological Inc Company Information
10.16.2 Sino Biological Inc Introduction and Business Overview
10.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sino Biological Inc Anti-PD-1 Antibody Products Offered
10.16.5 Sino Biological Inc Recent Development
10.17 3SBio Inc
10.17.1 3SBio Inc Company Information
10.17.2 3SBio Inc Introduction and Business Overview
10.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.17.4 3SBio Inc Anti-PD-1 Antibody Products Offered
10.17.5 3SBio Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-PD-1 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-PD-1 Antibody Industrial Chain Analysis
11.4 Anti-PD-1 Antibody Market Dynamics
11.4.1 Anti-PD-1 Antibody Industry Trends
11.4.2 Anti-PD-1 Antibody Market Drivers
11.4.3 Anti-PD-1 Antibody Market Challenges
11.4.4 Anti-PD-1 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-PD-1 Antibody Distributors
12.3 Anti-PD-1 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal
Table 2. Major Company of Polyclonal
Table 3. Global Anti-PD-1 Antibody Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Anti-PD-1 Antibody Sales by Type (2018-2024) & (Kg)
Table 5. Global Anti-PD-1 Antibody Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Anti-PD-1 Antibody Sales by Type (2018-2024) & (US& Million)
Table 7. Global Anti-PD-1 Antibody Market Share in Value by Type (2018-2024)
Table 8. Global Anti-PD-1 Antibody Price by Type (2018-2024) & (USD/g)
Table 9. Global Anti-PD-1 Antibody Sales by Type (2024-2029) & (Kg)
Table 10. Global Anti-PD-1 Antibody Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Anti-PD-1 Antibody Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Anti-PD-1 Antibody Sales Market Share in Value by Type (2024-2029)
Table 13. Global Anti-PD-1 Antibody Price by Type (2024-2029) & (USD/g)
Table 14. North America Anti-PD-1 Antibody Sales by Type (2018-2024) & (Kg)
Table 15. North America Anti-PD-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Anti-PD-1 Antibody Sales (Kg) by Type (2018-2024)
Table 17. Europe Anti-PD-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Anti-PD-1 Antibody Sales (Kg) by Type (2018-2024)
Table 19. Asia-Pacific Anti-PD-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Anti-PD-1 Antibody Sales (Kg) by Type (2018-2024)
Table 21. Latin America Anti-PD-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Anti-PD-1 Antibody Sales (Kg) by Type (2018-2024)
Table 23. Middle East and Africa Anti-PD-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Anti-PD-1 Antibody Sales by Company (2018-2024) & (Kg)
Table 25. Global Anti-PD-1 Antibody Sales Share by Company (2018-2024)
Table 26. Global Anti-PD-1 Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Anti-PD-1 Antibody Revenue Share by Company (2018-2024)
Table 28. Global Market Anti-PD-1 Antibody Price by Company (2018-2024) & (USD/g)
Table 29. Global Anti-PD-1 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into Anti-PD-1 Antibody Market
Table 33. Key Manufacturers Anti-PD-1 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anti-PD-1 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Anti-PD-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 37. Global Anti-PD-1 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Anti-PD-1 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Anti-PD-1 Antibody Sales Market Share in Value by Region (2018-2024)
Table 40. Global Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 41. Global Anti-PD-1 Antibody Sales by Region (2024-2029) & (Kg)
Table 42. Global Anti-PD-1 Antibody Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Anti-PD-1 Antibody Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Anti-PD-1 Antibody Sales Market Share in Value by Region (2024-2029)
Table 45. Global Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2024-2029)
Table 46. Global Anti-PD-1 Antibody Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Anti-PD-1 Antibody Sales by Application (2018-2024) & (Kg)
Table 48. Global Anti-PD-1 Antibody Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Anti-PD-1 Antibody Sales Market Share in Value by Application (2018-2024)
Table 51. Global Anti-PD-1 Antibody Price by Application (2018-2024) & (USD/g)
Table 52. Global Anti-PD-1 Antibody Sales by Application (2024-2029) & (Kg)
Table 53. Global Anti-PD-1 Antibody Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Anti-PD-1 Antibody Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Anti-PD-1 Antibody Sales Market Share in Value by Application (2024-2029)
Table 56. Global Anti-PD-1 Antibody Price by Application (2024-2029) & (USD/g)
Table 57. North America Anti-PD-1 Antibody Sales by Application (2018-2024) (Kg)
Table 58. North America Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Anti-PD-1 Antibody Sales by Application (2018-2024) (Kg)
Table 60. Europe Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Anti-PD-1 Antibody Sales by Application (2018-2024) (Kg)
Table 62. Asia-Pacific Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Anti-PD-1 Antibody Sales by Application (2018-2024) (Kg)
Table 64. Latin America Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Anti-PD-1 Antibody Sales by Application (2018-2024) (Kg)
Table 66. Middle East and Africa Anti-PD-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 68. North America Anti-PD-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Anti-PD-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Anti-PD-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 71. North America Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 72. North America Anti-PD-1 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Anti-PD-1 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Anti-PD-1 Antibody Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 76. Europe Anti-PD-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Anti-PD-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Anti-PD-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 80. Europe Anti-PD-1 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Anti-PD-1 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Anti-PD-1 Antibody Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 84. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2024-2029) & (Kg)
Table 88. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 92. Latin America Anti-PD-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Anti-PD-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Anti-PD-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 96. Latin America Anti-PD-1 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Anti-PD-1 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Anti-PD-1 Antibody Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 100. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 104. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Value by Country (2024-2029)
Table 107. Bio X Cell Company Information
Table 108. Bio X Cell Introduction and Business Overview
Table 109. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 110. Bio X Cell Anti-PD-1 Antibody Product
Table 111. Bio X Cell Recent Development
Table 112. Thermo Fisher Company Information
Table 113. Thermo Fisher Introduction and Business Overview
Table 114. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 115. Thermo Fisher Anti-PD-1 Antibody Product
Table 116. Thermo Fisher Recent Development
Table 117. InvivoGen Company Information
Table 118. InvivoGen Introduction and Business Overview
Table 119. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 120. InvivoGen Anti-PD-1 Antibody Product
Table 121. InvivoGen Recent Development
Table 122. BioVision Inc Company Information
Table 123. BioVision Inc Introduction and Business Overview
Table 124. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 125. BioVision Inc Anti-PD-1 Antibody Product
Table 126. BioVision Inc Recent Development
Table 127. Abcam Company Information
Table 128. Abcam Introduction and Business Overview
Table 129. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 130. Abcam Anti-PD-1 Antibody Product
Table 131. Abcam Recent Development
Table 132. Bristol-Myers Squibb (BMS) Company Information
Table 133. Bristol-Myers Squibb (BMS) Introduction and Business Overview
Table 134. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 135. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product
Table 136. Bristol-Myers Squibb (BMS) Recent Development
Table 137. Merck Company Information
Table 138. Merck Introduction and Business Overview
Table 139. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 140. Merck Anti-PD-1 Antibody Product
Table 141. Merck Recent Development
Table 142. Ono Pharmaceutical Co., Ltd Company Information
Table 143. Ono Pharmaceutical Co., Ltd Introduction and Business Overview
Table 144. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 145. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 146. Ono Pharmaceutical Co., Ltd Recent Development
Table 147. Lilly Company Information
Table 148. Lilly Introduction and Business Overview
Table 149. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 150. Lilly Anti-PD-1 Antibody Product
Table 151. Lilly Recent Development
Table 152. Chugai Pharmaceutical Co., Ltd Company Information
Table 153. Chugai Pharmaceutical Co., Ltd Introduction and Business Overview
Table 154. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 155. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 156. Chugai Pharmaceutical Co., Ltd Recent Development
Table 157. BeiGene Company Information
Table 158. BeiGene Introduction and Business Overview
Table 159. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 160. BeiGene Anti-PD-1 Antibody Product
Table 161. BeiGene Recent Development
Table 162. Abbvie Company Information
Table 163. Abbvie Introduction and Business Overview
Table 164. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 165. Abbvie Anti-PD-1 Antibody Product
Table 166. Abbvie Recent Development
Table 167. TG Therapeutics, Inc Company Information
Table 168. TG Therapeutics, Inc Introduction and Business Overview
Table 169. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 170. TG Therapeutics, Inc Anti-PD-1 Antibody Product
Table 171. TG Therapeutics, Inc Recent Development
Table 172. Novartis Company Information
Table 173. Novartis Introduction and Business Overview
Table 174. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 175. Novartis Anti-PD-1 Antibody Product
Table 176. Novartis Recent Development
Table 177. Arcus Biosciences Company Information
Table 178. Arcus Biosciences Introduction and Business Overview
Table 179. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 180. Arcus Biosciences Anti-PD-1 Antibody Product
Table 181. Arcus Biosciences Recent Development
Table 182. Sino Biological Inc Company Information
Table 183. Sino Biological Inc Introduction and Business Overview
Table 184. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 185. Sino Biological Inc Anti-PD-1 Antibody Product
Table 186. Sino Biological Inc Recent Development
Table 187. 3SBio Inc Company Information
Table 188. 3SBio Inc Introduction and Business Overview
Table 189. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 190. 3SBio Inc Anti-PD-1 Antibody Product
Table 191. 3SBio Inc Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Anti-PD-1 Antibody Market Trends
Table 195. Anti-PD-1 Antibody Market Drivers
Table 196. Anti-PD-1 Antibody Market Challenges
Table 197. Anti-PD-1 Antibody Market Restraints
Table 198. Anti-PD-1 Antibody Distributors List
Table 199. Anti-PD-1 Antibody Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-PD-1 Antibody Product Picture
Figure 2. Global Anti-PD-1 Antibody Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-PD-1 Antibody Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Anti-PD-1 Antibody Sales Status and Outlook (2018-2029) & (Kg)
Figure 5. Product Picture of Monoclonal
Figure 6. Global Monoclonal Sales YoY Growth (2018-2029) & (Kg)
Figure 7. Product Picture of Polyclonal
Figure 8. Global Polyclonal Sales YoY Growth (2018-2029) & (Kg)
Figure 9. Global Anti-PD-1 Antibody Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Anti-PD-1 Antibody Sales Market Share by Type in 2022 & 2029
Figure 11. North America Anti-PD-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America Anti-PD-1 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe Anti-PD-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anti-PD-1 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anti-PD-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anti-PD-1 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-PD-1 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-PD-1 Antibody Revenue in 2022
Figure 23. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of IHC-P
Figure 25. Global IHC-P Sales YoY Growth (2018-2029) & (Kg)
Figure 26. Product Picture of ICC/IF
Figure 27. Global ICC/IF Sales YoY Growth (2018-2029) & (Kg)
Figure 28. Product Picture of WB
Figure 29. Global WB Sales YoY Growth (2018-2029) & (Kg)
Figure 30. Product Picture of Flow Cytometry
Figure 31. Global Flow Cytometry Sales YoY Growth (2018-2029) & (Kg)
Figure 32. Product Picture of ELISA
Figure 33. Global ELISA Sales YoY Growth (2018-2029) & (Kg)
Figure 34. Global Anti-PD-1 Antibody Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Anti-PD-1 Antibody Sales Market Share by Application in 2022 & 2029
Figure 36. North America Anti-PD-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 37. North America Anti-PD-1 Antibody Sales Market Share in Value by Application in 2022
Figure 38. Europe Anti-PD-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. Europe Anti-PD-1 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Anti-PD-1 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Latin America Anti-PD-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Anti-PD-1 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Anti-PD-1 Antibody Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Anti-PD-1 Antibody Manufacturing Cost Structure
Figure 47. Anti-PD-1 Antibody Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed